Gene2us Overview
- Year Founded
-
2018
- Status
-
Private
- Latest Deal Type
-
Seed
- Investors
-
1
Gene2us General Information
Description
Provider of precision medicine services intended to facilitate personalized early diagnosis and health management. The company offers a miRNA database for disease and omics data analysis, including genome, transcriptome, proteome, metabolome, microbiome, and epigenome, enabling patients and healthcare providers to access personalized medical services for disease prediction and health monitoring.
Contact Information
Website
www.gene2us.co.krCorporate Office
- Room 608, 63, Buldang 36-gil
- Buldang-dong, Seobuk-gu
- Cheonan, Chungcheongnam
- South Korea
Corporate Office
- Room 608, 63, Buldang 36-gil
- Buldang-dong, Seobuk-gu
- Cheonan, Chungcheongnam
- South Korea
Gene2us Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 1. Seed Round | 01-Aug-2026 | Completed | Generating Revenue |
Gene2us Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Nautilus Investment (South Korea) | Venture Capital | Minority |
Gene2us FAQs
-
When was Gene2us founded?
Gene2us was founded in 2018.
-
Where is Gene2us headquartered?
Gene2us is headquartered in Cheonan, South Korea.
-
What industry is Gene2us in?
Gene2us’s primary industry is Laboratory Services (Healthcare).
-
Is Gene2us a private or public company?
Gene2us is a Private company.
-
What is Gene2us’s current revenue?
The current revenue for Gene2us is .
-
Who are Gene2us’s investors?
Nautilus Investment (South Korea) has invested in Gene2us.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process